Obesity Medication Prices Dropping: Access vs. Cost Controversy
The pharmaceutical market for obesity treatment is undergoing significant shifts as manufacturers adjust pricing strategies in response to heightened competition and evolving healthcare policy. In Sweden, the cost of certain GLP-1 receptor agonists used for weight management has seen downward pressure, a move that highlights the ongoing tension between pharmaceutical innovation, public health accessibility, and … Read more